ITMI932189A1 - PHARMACEUTICAL COMPOSITIONS CONTAINING N-ACETYL CARNOSINE FOR THE TREATMENT OF CATARACT - Google Patents

PHARMACEUTICAL COMPOSITIONS CONTAINING N-ACETYL CARNOSINE FOR THE TREATMENT OF CATARACT

Info

Publication number
ITMI932189A1
ITMI932189A1 IT93MI002189A ITMI932189A ITMI932189A1 IT MI932189 A1 ITMI932189 A1 IT MI932189A1 IT 93MI002189 A IT93MI002189 A IT 93MI002189A IT MI932189 A ITMI932189 A IT MI932189A IT MI932189 A1 ITMI932189 A1 IT MI932189A1
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
compositions containing
cataract
treatment
acetyl carnosine
Prior art date
Application number
IT93MI002189A
Other languages
Italian (it)
Inventor
Mark A Babizhayev
Costa Edoardo Bozzo
Original Assignee
Bruschettini Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bruschettini Srl filed Critical Bruschettini Srl
Priority to ITMI932189A priority Critical patent/IT1270905B/en
Publication of ITMI932189A0 publication Critical patent/ITMI932189A0/en
Priority to AU78127/94A priority patent/AU7812794A/en
Priority to PCT/EP1994/003340 priority patent/WO1995010294A1/en
Publication of ITMI932189A1 publication Critical patent/ITMI932189A1/en
Application granted granted Critical
Publication of IT1270905B publication Critical patent/IT1270905B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Abstract

La presente invenzione ha per oggetto l'uso della N-acetilcarnosina per la fabbricazione di un medicamento utile nella prevenzione e terapia della cataratta e composizioni farmaceutiche contenenti N-acetilcarnosina come principio attivo.The present invention relates to the use of N-acetylcarnosine for the manufacture of a medicament useful in the prevention and therapy of cataracts and pharmaceutical compositions containing N-acetylcarnosine as an active ingredient.

ITMI932189A 1993-10-15 1993-10-15 PHARMACEUTICAL COMPOSITIONS CONTAINING N-ACETYLCARNOSINE FOR THE TREATMENT OF CATARACT IT1270905B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI932189A IT1270905B (en) 1993-10-15 1993-10-15 PHARMACEUTICAL COMPOSITIONS CONTAINING N-ACETYLCARNOSINE FOR THE TREATMENT OF CATARACT
AU78127/94A AU7812794A (en) 1993-10-15 1994-10-10 Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
PCT/EP1994/003340 WO1995010294A1 (en) 1993-10-15 1994-10-10 Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI932189A IT1270905B (en) 1993-10-15 1993-10-15 PHARMACEUTICAL COMPOSITIONS CONTAINING N-ACETYLCARNOSINE FOR THE TREATMENT OF CATARACT

Publications (3)

Publication Number Publication Date
ITMI932189A0 ITMI932189A0 (en) 1993-10-15
ITMI932189A1 true ITMI932189A1 (en) 1995-04-15
IT1270905B IT1270905B (en) 1997-05-13

Family

ID=11367036

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI932189A IT1270905B (en) 1993-10-15 1993-10-15 PHARMACEUTICAL COMPOSITIONS CONTAINING N-ACETYLCARNOSINE FOR THE TREATMENT OF CATARACT

Country Status (3)

Country Link
AU (1) AU7812794A (en)
IT (1) IT1270905B (en)
WO (1) WO1995010294A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2141483C1 (en) * 1997-07-04 1999-11-20 Небольсин Владимир Евгеньевич Peptide derivatives or their pharmaceutically acceptable salts, method of their synthesis, use and pharmaceutical composition
NO993678L (en) * 1999-07-28 2001-01-29 Norsk Hydro As Feed for salmonids
AUPR038200A0 (en) * 2000-09-26 2000-10-19 Beta Peptide Foundation Pty Ltd, The Compositions and methods for delaying, preventing, rejuvenating or reversing senescence
US7795203B2 (en) * 2002-09-30 2010-09-14 Babizhayev Mark A Method for topical treatment of eye disease and composition and device for said treatment
WO2004064866A1 (en) * 2003-01-20 2004-08-05 Innovative Vision Products, Inc. Combined use of carnosinase inhibitor with l-carnosines and composition
WO2005041870A2 (en) 2003-10-24 2005-05-12 Ader Enterprises, Inc. Composition and method for the treatment of eye disease
US7776364B2 (en) 2006-03-24 2010-08-17 Advanced Scientific, Llc Non-surgical method for treating cataracts in mammals including man
KR102394087B1 (en) 2014-07-31 2022-05-03 콘시글리오 나치오날레 델레 리체르체 Derivatives obtained from hyaluronic acid and carnosine
ES2632808T3 (en) 2014-09-04 2017-09-15 Nicox Science Ireland Carnosine compounds donors of nitric oxide
IT202000014017A1 (en) 2020-06-11 2021-12-11 Fidia Farm Spa NEW DERIVATIVES OBTAINED FROM HYALURONIC ACID AND CARNOSINE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5640613A (en) * 1979-09-13 1981-04-16 Nippon Chemiphar Co Ltd Novel type remedy for peptic ulcer
EP0436611A4 (en) * 1988-09-28 1992-03-11 Peptide Technology Ltd Compound and method for the retardation of collagen cross-linking
DE69231576T2 (en) * 1991-09-09 2001-06-13 Peptech Ltd Use of peptides TO TREAT COMPLICATIONS AND PATHOLOGY IN DIABETES

Also Published As

Publication number Publication date
IT1270905B (en) 1997-05-13
WO1995010294A1 (en) 1995-04-20
ITMI932189A0 (en) 1993-10-15
AU7812794A (en) 1995-05-04

Similar Documents

Publication Publication Date Title
YU13695A (en) Application of 2-phenyl-3-aroylbenzothiophene and pharmaceutical formulations thereof
EA200201271A1 (en) INHIBITORS 11-BETA-HYDROXYSTEROID DEGYDROGENASE TYPE 1
AU2003225617A1 (en) Thiadiazolylpiperazine derivatives useful for treating or preventing pain
AU2002225772A1 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
BR0313148A (en) Controlled release formulations comprising lamotrigine
ES2092890T3 (en) APPLICATION OF RILUZOLE IN THE TREATMENT OF PARKINSON'S DISEASE AND PARKINSON'S SYNDROMES.
GEP20002332B (en) Cefalosporin Derivatives
ES2062610T3 (en) DIARILIC ANTI-ATEROSCLEROTIC COMPOUND.
ITMI932189A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING N-ACETYL CARNOSINE FOR THE TREATMENT OF CATARACT
ATE213633T1 (en) MEDICINAL CONTAINING LAMOTRIGINE
EA199801028A1 (en) APPLICATION OF DERIVATIVES OF P-AMINOPHENOL FOR PREPARATION OF PHARMACEUTICAL COMPOSITIONS USED IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
BG106155A (en) Novel derivatives and analogues of galanthamin
DK0736029T3 (en) Anticonvulsant pseudofructopyranose sulfamates
ZA922910B (en) Heterocylic pharmaceutical compounds preparation and use
ITRM910730A1 (en) PHARMACEUTICAL COMPOSITIONS, FOR TOPICAL USE, CONTAINING "SCAVENGERS" OF FREE OXYGEN RADICALS AND ANTIBACTERIALS, INDICATED IN THE THERAPY OF SURFACE TISSUES.
GEP20043377B (en) Pharmaceutical Complex
HUP9701293A2 (en) New salts without unsavoury taste and pharmaceutical compositions containing them
GEP20053512B (en) S-Methyl-Dihydro-Ziprasidone for Treatment of Psychiatric and Ocular Disorders.
ATE293445T1 (en) PRODUCTION OF PURE STEREOISOMERS OF TRICYCLO-(5.2.1.0(2.6))-DEC-9-YL-XANTHOGENATE AND THEIR USE AS MEDICINAL PRODUCTS
GB9505082D0 (en) Medicament
EA200401295A1 (en) STATIN THERAPY TO ENHANCE SUPPORT OF COGNITIVE FUNCTION
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
NO950177D0 (en) Pharmacologically active derivatives
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
EP0651741A1 (en) N?g -monomethyl-l-arginine hydrochloride derivatives and their use in the treatment of septic shock.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971029